 You know, I think it's to change people's minds, right? What you can do in a place like this is really change people's minds and we've changed the conversation in Australia. You know, that's a big turnaround from where we were even in even a year or so ago. I'm Professor Mal McLeod, I'm a research chemist from the Australian National University and I help out with the CanTest Health and Drug Checking Service which is where we're located and of course there's a lot of analytical chemistry that goes on here. At one level it's sort of the basic thing that chemists do, right, is identify substances, make substances, identify substances and so we're pretty good at that but what this service does is really brings it home. It's really a nice application of the chemistry that we routinely do and I think an outcome of that is that we're really successfully able to monitor the drug market in Australia and particularly locally here in Canberra. So when new things do pop up we're able to identify them and we're able to alert the community and here's our little sample. It's in a vial but we get pills, we get capsules, we get powders, so let's have a go at running this. You just need a tiny amount of substance and pop it over the middle, enter the name and away we go. We've got codeine base is the first first match, scores a little bit low so normally we say if the score is over 750 we're very confident. When the client is ready for the testing they come in, they're in here with the analysts and we run the tests. So there's a few things we do. We've got got a balance down the front here where we weigh the sample, we take some photos, there's an FTIR machine we talked about earlier. Again this is really good at identifying drugs that we find and over here this big beast this is the UPLC machine. This can separate drugs, it can identify them and it can tell us something about their purity. Just about every shift if something pops up you know my phone will go ping. You know we've got something here, we don't know what it is and we'll formulate a response to that. You know is it something we are concerned about? Do we bring it back to ANU? Do we look further at it? At the CanTest service we can provide clients with information about you know the drug contents, the purity sometimes of the drugs that they're presenting to us but on occasion we do find new things or unexpected things and in that case we have to do more and so that's when we bring it back to the ANU for further work. One of the early things that we discovered was a new ketamine derivative. We were one of the first labs in the world to identify this as far as we know and the first drug checking service to identify it. So the compound is called 2-fluoro-2-oxo-PCE and the real message here is this is a this is a new substance and we don't know much about it so there could be elevated risks associated with this compound. Look I think it's been really really important we've had a really strong uptake of clients coming into the service and in every case they're learning something about the drugs that they've got in their possession and they're learning about the risks associated with those drugs and how to stay a bit safer. We've all got a lot out of it like I said it's a really great way to apply the knowledge that we have to a real real world problem not just hiding away in our lab.